SIGA Vol Fri>>
Volume ------i>1,923,460
Avg. Volume ---->443,735
The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox in 2018, and was approved by the EMA for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in January 2022 .
SIGA SIGA Technologies, Inc.- If This Monkeypox comes back...
$6.25 0.36(+6.11%)4:00 PM 12/08/23
NASDAQ |$USD |Post-Market:$6.29+0.04(+0.64%)7:26 PM
Volume ------i>1,923,460
Avg. Volume ---->443,735
The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox in 2018, and was approved by the EMA for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in January 2022 .
SIGA SIGA Technologies, Inc.- If This Monkeypox comes back...
$6.25 0.36(+6.11%)4:00 PM 12/08/23
NASDAQ |$USD |Post-Market:$6.29+0.04(+0.64%)7:26 PM